El Cima Universidad de Navarra y Caja Rural de Navarra impulsan el desarrollo de nuevas terapias contra el cáncer

by CIMA - Centro de Investigación Médica Aplicada

Las dos instituciones han firmado un convenio centrado en tres proyectos científicos sobre estrategias combinadas de inmunoterapia, moléculas para estimular el sistema inmune y terapias CAR-T

Read more

IBEC and ISGlobal scientists develop an innovative compound effective against malaria and leishmaniasis

by IBEC - Institut de Bioenginyeria de Catalunya

A study led by IBEC and ISGlobal has demonstrated the antileishmanial potential of an antimalarial compound. Initially designed for malaria, this drug shows high efficacy against leishmaniasis, repres...

Read more

The PEACHD European project is launched to improve cancer prevention in specific vulnerable groups in Europe

by Fundació Clínic per a la Recerca Biomèdica

Endowed with 1.25 million euros, the project is coordinated by IDIBAPS’ Clinical Addictions Research Group (GRAC-GRE), which is led by Hugo López-Pelayo, a researcher and medical specialist at Hosp...

Read more

Rethinking clinical trial design for rare tumors

by VHIO

In an international study, they propose optimizing the design of clinical trials in rare tumors to speed up the study and approval of new drugs that will make it possible to respond to patients with t...

Read more

IRB Barcelona champions Rare Disease Day

by IRB Barcelona - Instituto de Investigación Biomédica

In the fight against these diseases, at IRB Barcelona, they are committed to interdisciplinary research through new projects aimed at better understanding rare diseases and developing new therapies an...

Read more

The Myotonic Dystrophy Type 1 Network (Red-DM) launches its official webpage

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

​The Nucleic Acids Chemistry group, led by Prof. Ramon Eritja’s of the IQAC (CSIC), is participating in a multidisciplinary network for Myotonic Dystrophy Type 1 (DM1) with other 6 research groups...

Read more

Los caninos revelan nuevas claves para la estimación del sexo de poblaciones humanas

by CENIEH - Centro Nacional de Investigación sobre la Evolución Humana

Describen las principales diferencias morfológicas existentes en las estructuras internas de los colmillos de hombres y mujeres de poblaciones actuales y destaca la utilidad de esta pieza dental para...

Read more

Magnetic resonance surveillance reduces mortality in women at high risk of BRCA1 breast cancer as an alternative to preventive mastectomy

by Hospital de la Santa Creu i Sant Pau

The study analyzes data from women with pathogenic variants of the BRCA1 or BRCA2 genes and shows that those with BRCA1 sequence variations undergoing magnetic resonance imaging follow-up have a signi...

Read more

Investigating Fragile X syndrome in girls and adolescents

by Instituto de Investigación e Innovación Parc Taulí

In this context, the doctoral thesis of the Lorena Joga, child and youth neuropsychologist at Parc Taulí and member of the I3PT Growth and Developmental Disorders Research Group, with the title "Frag...

Read more

A European project led by IDIBAPS will test a diagnostic genomic test for breast cancer to improve patients' quality of life

by Fundació Clínic per a la Recerca Biomèdica

The DEFINITIVE project, led by IDIBAPS, will be conducted across 44 hospitals in a total of 7 European and associated countries to demonstrate that use of genomic test HER2DX® improves quality of lif...

Read more

Anti-cancer drug could improve symptoms after stroke

by Universitat Autònoma de Barcelona (UAB)

It has been demonstrated in animal models the benefits of vorinostat after having suffered a stroke. The drug, used in humans to treat cutaneous T-cell lymphoma, has been proved to mitigate brain inju...

Read more

PBF-999, the first in class treatment in development for the Prader-Willi Syndrome has received “Orphan Drug Designation” by the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA)

by Palobiofarma

The Orphan Drug Designation indicates the acknowledgement by the Regulatory Authorities of USA and the EU that PBF-999 have the potential to address the specific needs of individuals suffering from Pr...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream